查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
脑炎治疗市场与 COVID-19 影响分析，按类型、治疗、症状、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1335280

脑炎治疗市场与 COVID-19 影响分析，按类型、治疗、症状、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Encephalitis Treatment Market with COVID-19 Impact Analysis, By Type, By Treatment, By Symptoms, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年脑炎治疗市场规模为201.089亿美元，2023年至2030年復合年增长率为5.3%。

脑炎治疗市场-市场动态：

  • 脑炎患病率不断上升推动市场增长。
  • 预计脑炎病例的增加将推动全球脑炎治疗市场的发展。一种随着时间的推移而变得更严重的挥之不去的脑部炎症称为 CFE。大脑的大脑半球经常受到炎症的影响，从而导致严重的癫痫活动，例如反復发作的局灶性癫痫发作。由于持续的脑部炎症，患有 CFE 的人可能会出现不可挽回的脑损伤、运动能力丧失和精神恶化。这种疾病主要影响 2 至 10 岁的儿童，全球仅记录了 200 至 500 例病例。因此，上述事实支持预测期内的市场增长。

脑炎治疗市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，预计全球脑炎治疗市场在预测期内（2023-2030）每年将以 5.3% 左右的复合年增长率增长
  • 由于全球脑炎的高发病率，预计脑炎治疗行业将以显着的速度增长
  • 根据类型细分，预计主要细分市场将在预测期内主导市场
  • 从地区来看，预计北美将在预测期内主导市场

脑炎治疗市场-細項分析：

  • 全球脑炎治疗市场根据类型、治疗、症状、最终用户和地区进行细分。
  • 根据类型，市场分为初级市场和次级市场。预计主要细分市场将在预测期内主导市场。该细分市场的增长归因于原发性脑炎相对于继发性脑炎的患病率不断上升。原发性脑炎是指由感染原直接引起脑部炎症，而身体其他部位没有任何先前感染的情况。引起原发性脑炎的常见传染源包括单纯疱疹病毒 (HSV)、西尼罗河病毒 (WNV) 和肠道病毒等病毒。 HSV 脑炎是最严重的原发性脑炎之一，需要立即就医。如果不及时治疗，可能会导致严重的脑损伤和神经并发症。从而推动细分市场的扩张。

脑炎治疗市场-地理洞察：

从地域上看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。预计北美将在预测期内主导市场。脑炎病例遍布北美，其患病率因地区和脑炎类型（例如病毒性、自身免疫性）而异。据报导，病毒性脑炎，例如单纯疱疹脑炎，是美国散发性脑炎的主要原因之一。此外，北美，特别是美国，一直处于脑炎研究和临床试验的前沿。许多学术机构、製药公司和研究组织都积极参与脑炎发病机制的研究、确定新的治疗方式和探索潜在的疫苗。因此，预计这将推动该地区的市场增长。

脑炎治疗市场-竞争格局：

全球脑炎治疗市场的领先公司正在加大研发力度，以使其产品多样化。此外，这些市场参与者利用战略联盟和合作伙伴关係来促进增长。市场上的主要参与者包括艾尔建、默克公司、辉瑞公司、葛兰素史克公司、Melinta Therapeutics LLC、Basilea Pharmaceutica Ltd.、雅培、F. Hoffmann-La Roche Ltd.、Mylan NV、Teva Pharmaceutical Industries Ltd.、赛诺菲、诺华公司、拜耳公司、Sun Pharmaceutical Industries Ltd.、Aurobindo Pharma、Lupin、艾伯维公司、Cumberland Pharmaceuticals Inc.、礼来公司、Endo International plc、Zydus Cadila 和Fresenius Kabi AG。

最近的发展：

2021 年 8 月，蜱传脑炎 (TBE) 疫苗（称为 TICOVAC）获得美国食品和药物管理局 (USFDA) 批准。在野外，它可以产生 TBE 病毒中和抗体。白蛋白是人类血液的一种成分，存在于 TICOVAC 中。由于有效的供体筛选和产品加工程序，病毒传播和变异型克雅氏病 (vCJD) 传播的可能性极低。

该研究的主要特点：

  • 这项关于脑炎治疗市场的拟议研究提供了市场规模（百万美元）、年复合成长率（CAGR%）和预测估计（2023-2030），以 2022 年为基准年
  • 该报告为客户提供有关脑炎治疗市场的最新趋势见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并解释了脑炎治疗市场有吸引力的投资主张矩阵
  • 总体报告确定了新的投资机会、老牌参与者面临的挑战以及脑炎治疗市场维持的增长因素
  • COVID-19 对脑炎治疗市场规模、预测、复合年增长率和市场动态的影响将在研究范围下详细讨论。还将涵盖新冠疫情后脑炎治疗市场的详细见解。
  • 为了让本报告的用户全面了解脑炎治疗市场，我们还包括了脑炎治疗市场的竞争格局和关键创新者分析。
  • 该研究包括增长前景映射分析，其中所有行业细分都根据其市场规模、增长率和吸引力进行基准测试。
  • 该报告提供了主要市场参与者的详细公司概况，这将帮助用户了解脑炎治疗市场参与者的财务信息和战略倡议。
  • 此外，报告还揭示了全球和区域市场主要参与者的重要收购和兼併、合作和合资、新产品推出、研发、区域扩张。
  • 全球脑炎治疗市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和财务分析师

目录

第一章：脑炎治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的脑炎治疗市场片段
    • 脑炎治疗市场片段（按治疗）
    • 按症状分類的脑炎治疗市场片段
    • 最终用户的脑炎治疗市场片段
    • 按国家/地区分類的脑炎治疗市场片段
    • 按地区分類的脑炎治疗市场片段
  • 竞争洞察

第 3 章：脑炎治疗主要市场趋势

  • 脑炎治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 脑炎治疗市场限制
    • 市场限制影响分析
  • 脑炎治疗市场机会
  • 脑炎治疗市场未来趋势

第 4 章：脑炎治疗行业研究

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 规范架构分析

第 5 章：脑炎治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的细分市场
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：脑炎治疗市场格局

  • 2022 年脑炎治疗市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：脑炎治疗市场 - 按类型

  • 概述
    • 按类型分類的细分市场份额分析
    • 原发性脑炎
    • 继发性脑炎

第 8 章：脑炎治疗市场 - 按治疗分类

  • 概述
    • 按处理方式分類的细分市场份额分析
    • 抗病毒剂
    • 类固醇注射
    • 抗生素
    • 免疫球蛋白治疗
    • 血浆分离术
    • 其他的

第 9 章：脑炎治疗市场 - 按症状

  • 概述
    • 按症状分类的细分市场份额分析
    • 发烧
    • 睡意
    • 头痛
    • 性格改变
    • 易怒
    • 错乱
    • 弱点
    • 癫痫发作
    • 其他的

第 10 章：脑炎治疗市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场份额分析
    • 诊所
    • 医院
    • 其他的

第 11 章：脑炎治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场份额分析
  • 北美
    • 概述
    • 北美脑炎治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按不同处理方式）
    • 北美市场规模和预测（按症状）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲脑炎治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按类型）
    • 欧洲市场规模和预测（按处理方式）
    • 欧洲市场规模和预测（按症状）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区脑炎治疗主要製造商
    • 亚太地区市场规模和预测（按国家）
    • 亚太地区市场规模和预测（按类型）
    • 亚太地区市场规模和预测（按不同处理方式）
    • 亚太地区市场规模和预测（按症状）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉美
    • 概述
    • 拉丁美洲脑炎治疗主要製造商
    • 拉丁美洲市场规模和预测（按国家）
    • 拉丁美洲市场规模和预测（按类型）
    • 拉丁美洲市场规模和预测（按不同处理方式）
    • 拉丁美洲市场规模和预测（按症状）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲脑炎治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按不同处理方式）
    • 中东和非洲市场规模及预测（按症状）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 火鸡
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第12章：主要供应商分析-脑炎治疗行业

  • 竞争仪表板
  • 公司简介
    • Allergan
    • Merck & Co., Inc.
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Melinta Therapeutics LLC
    • Basilea Pharmaceutica Ltd.
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Novartis AG
    • Bayer AG
    • Sun Pharmaceutical Industries Ltd.
    • Aurobindo Pharma
    • Lupin
    • AbbVie Inc.
    • Cumberland Pharmaceuticals Inc.
    • Eli Lilly and Company
    • Endo International plc
    • Zydus Cadila
    • Fresenius Kabi AG

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联繫我们
Product Code: ANV1573

REPORT HIGHLIGHT

Encephalitis Treatment Market size was valued at USD 20,108.9 Million in 2022, expanding at a CAGR of 5.3% from 2023 to 2030.

An infection or an inflammatory reaction that affects the brain's active tissues might result in encephalitis. The goal of encephalitis treatment is to reduce head swelling and avert complications. Intravenous antibiotics can be administered to treat encephalitis if a bacterial infection is to blame. Herpes-related encephalitis is treated with supportive care and intravenous antiviral drugs including acyclovir. The patient should also be kept hydrated, their temperature should be reduced, and seizures should be treated, and any pressure in their skull should be eased.

Encephalitis Treatment Market- Market Dynamics:

  • Growing prevalence of encephalitis to propel market growth.
  • An increase in encephalitis cases is anticipated to fuel the global market for encephalitis treatments. A type of lingering brain inflammation that becomes worse over time is called CFE. The cerebral hemisphere of the brain is often affected by inflammation, which causes severe epileptic activity such as recurring focal seizures. Because of the ongoing brain inflammation, people with CFE may have irreparable brain damage, loss of motor abilities, and mental deterioration. The sickness mostly affects children between the ages of 2 and 10, and there have only been 200-500 recorded cases worldwide. Thereby, the aforementioned facts support the market growth during the forecast period.

Encephalitis Treatment Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Encephalitis Treatment market is estimated to grow annually at a CAGR of around 5.3% over the forecast period (2023-2030)
  • The Encephalitis Treatment industry is projected to grow at a significant rate owing to the high prevalence of encephalitis across the globe
  • Based on type segmentation, the primary segment is expected to dominate the market during the forecast period
  • Based on region, North America is expected to dominate the market over the forecast period

Encephalitis Treatment Market- Segmentation Analysis:

  • The Global Encephalitis Treatment Market is segmented based on type, treatment, symptoms, end user, and Region.
  • Based on type, the market is bifurcated into primary and secondary. The primary segment is expected to dominate the market during the forecast period. The segment growth is attributed to the growing prevalence of primary encephalitis over secondary encephalitis. Primary encephalitis refers to cases where the inflammation of the brain is directly caused by an infectious agent, without any prior infection in other parts of the body. Common infectious agents causing primary encephalitis include viruses like herpes simplex virus (HSV), West Nile virus (WNV), and enteroviruses. HSV encephalitis is one of the most severe forms of primary encephalitis and requires immediate medical attention. It can lead to significant brain damage and neurological complications if not treated promptly. Thereby, driving the segment expansion.

Encephalitis Treatment Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. Encephalitis cases occur throughout North America, with varying prevalence rates depending on the region and the type of encephalitis (e.g., viral, autoimmune). Viral encephalitis, such as herpes simplex encephalitis, has been reported to be one of the leading causes of sporadic encephalitis in the United States. Moreover, North America, particularly the United States, has been at the forefront of encephalitis research and clinical trials. Many academic institutions, pharmaceutical companies, and research organizations are actively involved in studying the pathogenesis of encephalitis, identifying new treatment modalities, and exploring potential vaccines. Thus, this is expected to drive the market growth in the region.

Encephalitis Treatment Market- Competitive Landscape:

Leading companies in the worldwide Encephalitis Treatment market are stepping up their R&D efforts to diversify their product offerings. Additionally, these market participants use strategic alliances and partnerships that promote growth. The key players operating in the market include Allergan, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Abbott, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, AbbVie Inc., Cumberland Pharmaceuticals Inc., Eli Lilly and Company, Endo International plc, Zydus Cadila, and Fresenius Kabi AG.

Recent Developments:

In August 2021, the Tick-Borne Encephalitis (TBE) vaccine, known as TICOVAC, was approved by the United States Food and Drug Administration (USFDA). In the wild, it can generate TBE virus-neutralizing antibodies. Albumin, a component of human blood, is present in TICOVAC. Virus transmission and variant Creutzfeldt-Jakob disease (vCJD) transmission are extremely unlikely due to effective donor screening and product processing procedures.

Key features of the study:

  • This proposed research study on Encephalitis Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Encephalitis Treatment market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Encephalitis Treatment market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Encephalitis Treatment market
  • Impact of COVID-19 on Encephalitis Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Encephalitis Treatment market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Encephalitis Treatment market, we have also included competitive landscape and key innovator analysis for the Encephalitis Treatment market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Encephalitis Treatment market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Encephalitis Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENCEPHALITIS TREATMENT MARKET KEY PLAYERS

  • Allergan
  • Merck & Co., Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Melinta Therapeutics LLC
  • Basilea Pharmaceutica Ltd.
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Novartis AG
  • Bayer AG
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Lupin
  • AbbVie Inc.
  • Cumberland Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Endo International plc
  • Zydus Cadila
  • Fresenius Kabi AG

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY TYPE

  • Primary Encephalitis
  • Secondary Encephalitis

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY TREATMENT

  • Antiviral Agents
  • Steroid Injection
  • Antibiotics
  • Immunoglobulin Therapy
  • Plasmapheresis
  • Others

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY SYMPTOMS

  • Fever
  • Drowsiness
  • Headaches
  • Personality Changes
  • Irritability
  • Confusion
  • Weakness
  • Seizures
  • Others

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY END USER

  • Clinic
  • Hospital
  • Others

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Encephalitis Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Encephalitis Treatment Market Snippet by Type
    • 2.1.2. Encephalitis Treatment Market Snippet by Treatment
    • 2.1.3. Encephalitis Treatment Market Snippet by Symptoms
    • 2.1.4. Encephalitis Treatment Market Snippet by End User
    • 2.1.5. Encephalitis Treatment Market Snippet by Country
    • 2.1.6. Encephalitis Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Encephalitis Treatment Key Market Trends

  • 3.1. Encephalitis Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Encephalitis Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Encephalitis Treatment Market Opportunities
  • 3.4. Encephalitis Treatment Market Future Trends

4. Encephalitis Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Encephalitis Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Encephalitis Treatment Market Landscape

  • 6.1. Encephalitis Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Encephalitis Treatment Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Primary Encephalitis
    • 7.1.3. Secondary Encephalitis

8. Encephalitis Treatment Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
    • 8.1.2. Antiviral Agents
    • 8.1.3. Steroid Injection
    • 8.1.4. Antibiotics
    • 8.1.5. Immunoglobulin Therapy
    • 8.1.6. Plasmapheresis
    • 8.1.7. Others

9. Encephalitis Treatment Market - By Symptoms

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Symptoms, 2022 & 2030 (%)
    • 9.1.2. Fever
    • 9.1.3. Drowsiness
    • 9.1.4. Headaches
    • 9.1.5. Personality Changes
    • 9.1.6. Irritability
    • 9.1.7. Confusion
    • 9.1.8. Weakness
    • 9.1.9. Seizures
    • 9.1.10. Others

10. Encephalitis Treatment Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 10.1.2. Clinic
    • 10.1.3. Hospital
    • 10.1.4. Others

11. Encephalitis Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Encephalitis Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Encephalitis Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Encephalitis Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Encephalitis Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Encephalitis Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Encephalitis Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Allergan
    • 12.2.2. Merck & Co., Inc.
    • 12.2.3. Pfizer Inc.
    • 12.2.4. GlaxoSmithKline plc
    • 12.2.5. Melinta Therapeutics LLC
    • 12.2.6. Basilea Pharmaceutica Ltd.
    • 12.2.7. Abbott
    • 12.2.8. F. Hoffmann-La Roche Ltd.
    • 12.2.9. Mylan N.V.
    • 12.2.10. Teva Pharmaceutical Industries Ltd.
    • 12.2.11. Sanofi
    • 12.2.12. Novartis AG
    • 12.2.13. Bayer AG
    • 12.2.14. Sun Pharmaceutical Industries Ltd.
    • 12.2.15. Aurobindo Pharma
    • 12.2.16. Lupin
    • 12.2.17. AbbVie Inc.
    • 12.2.18. Cumberland Pharmaceuticals Inc.
    • 12.2.19. Eli Lilly and Company
    • 12.2.20. Endo International plc
    • 12.2.21. Zydus Cadila
    • 12.2.22. Fresenius Kabi AG

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Encephalitis Treatment Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Encephalitis Treatment Market, by Type 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: Treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Encephalitis Treatment Market, by Treatment 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: Symptoms Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Symptoms
  • TABLE Global Encephalitis Treatment Market, by Symptoms 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Encephalitis Treatment Market, by End User 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Encephalitis Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Encephalitis Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Treatment segment market share analysis, 2022 & 2030
  • FIGURE Treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Symptoms segment market share analysis, 2022 & 2030
  • FIGURE Symptoms segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Europe Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Asia Pacific Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Latin America Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Middle East and Africa Encephalitis Treatment Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE Germany Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE India Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE Brazil Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE Saudi Arabia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)